Dr. Furberg is a molecular epidemiologist conducting research to identify factors associated with genitourinary cancer etiology and prognosis. She is Co-PI of the MSK Urothelial Cancer Registry, an institutional resource to identify genetic and non-genetic factors associated with bladder cancer risk and outcomes. She is PI of an American Cancer Society-funded grant to conduct a prospective study to determine the impact of post-diagnosis smoking on bladder cancer recurrence risk and BCG treatment. She is also funded to identify germline genetic variants that are associated with response to platinum-based chemotherapy in bladder cancer patients. Together with clinical colleagues at MSK, Weill Cornell and the University of Waterloo, she is investigating the prognostic relevance of body size in urologic malignancies with an emphasis on the obesity paradox in kidney cancer.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Helena Furberg discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
View all disclosures